Pulmonologists share best practices on when primary care providers should consider sending patients with respiratory ...

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

Canada is just emerging from another winter wave of multiple infectious diseases only for the population to be confronted ...

In a statement today, GlaxoSmithKline Malaysia (GSK) highlighted that RSV is a common and highly contagious virus that can lead to serious health complications, including lower respiratory tract ...

The Global Active Pharmaceutical Ingredients Market achieved a valuation of $209.80 Billion in 2024 and is anticipated to ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares ...

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today ...

GlaxoSmithKline recently held a high-level scientific conference in conjunction with the launch of “Bexsero,” the first ...

Abu Dhabi Global Health Week today honoured exceptional individuals and institutions from around the world whose innovative ...

London: British pharmaceutical major GlaxoSmithKline (GSK) has failed to meet the required regulatory and ethical standards ...

Pharmaceuticals are currently exempt from a baseline 10 per cent tax Mr Trump has placed on goods entering the US, but the US ...

Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...